Uniphar (LON:UPR) Reaches New 1-Year Low – Here’s What Happened

Uniphar plc (LON:UPR) hit a new 52-week low during mid-day trading on Tuesday . The stock traded as low as GBX 166 ($2.10) and last traded at GBX 166.65 ($2.11), with a volume of 19668 shares traded. The stock had previously closed at GBX 171.50 ($2.17).

Analysts Set New Price Targets

Separately, Deutsche Bank Aktiengesellschaft reissued a “buy” rating and issued a GBX 310 ($3.93) price objective on shares of Uniphar in a research report on Wednesday, September 4th.

Uniphar Trading Down 2.8 %

The company has a debt-to-equity ratio of 119.43, a current ratio of 0.90 and a quick ratio of 0.60. The company has a market capitalization of £454.99 million, a PE ratio of 1,232.14 and a beta of 0.75. The company’s fifty day moving average is GBX 205.67 and its 200-day moving average is GBX 213.63.

Uniphar Cuts Dividend

The firm also recently declared a dividend, which was paid on Friday, October 4th. Shareholders of record on Thursday, September 12th were paid a €0.01 ($0.01) dividend. This represents a yield of 0.25%. The ex-dividend date of this dividend was Thursday, September 12th. Uniphar’s dividend payout ratio (DPR) is presently 1,428.57%.

Uniphar Company Profile

Uniphar plc operates as a diversified healthcare services company in the Republic of Ireland, the United Kingdom, The Netherlands, and internationally. The company operates through three divisions: Medtech, Pharma, and Supply Chain & Retail. The Medtech division offers outsourced sales; and marketing, distribution, and support services to medical device manufacturers.